One possible explanation for myeloid neoplasms with both SF3B1 and PHF6 mutations not having been reported in the literature may be the lack of large-scale studies of myeloid neoplasms that have been assessed for PHF6 mutations. This evidence concerns the gene PHF6 and myeloid neoplasm.